Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs.
作者信息
Daali Youssef, Rostami-Hodjegan Amin, Samer Caroline F
机构信息
Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Geneva, Switzerland.
出版信息
Front Pharmacol. 2022 Jan 18;12:834717. doi: 10.3389/fphar.2021.834717. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs.社论：精准医学：细胞色素P450和转运体基因多态性、药物相互作用、疾病对药物安全性和有效性的影响
Front Pharmacol. 2022 Jan 18;12:834717. doi: 10.3389/fphar.2021.834717. eCollection 2021.
2
Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug Interactions.基于生理学的药代动力学（PBPK）模型在药物吸收、清除和药物-药物相互作用中的应用。
Curr Drug Metab. 2021;22(7):523-531. doi: 10.2174/1389200221999210101233340.
3
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine.生理药代动力学（PBPK）模型在个性化医疗中纳入临床状况的实用性。
J Pharm Sci. 2017 Sep;106(9):2380-2391. doi: 10.1016/j.xphs.2017.04.035. Epub 2017 Apr 26.
4
The Promises of Quantitative Proteomics in Precision Medicine.定量蛋白质组学在精准医学中的前景
J Pharm Sci. 2017 Mar;106(3):738-744. doi: 10.1016/j.xphs.2016.11.017. Epub 2016 Dec 8.
5
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.基于生理的药代动力学/药效学建模，以预测CYP2C9基因多态性、联合用药及制剂对氟比洛芬药代动力学和药效学的影响。
Pharmaceutics. 2020 Nov 2;12(11):1049. doi: 10.3390/pharmaceutics12111049.
6
Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends.回顾用于预测代谢性药物-药物相互作用的PBPK模型开发所整合的数据：转变观点与新趋势
Front Pharmacol. 2021 Oct 28;12:708299. doi: 10.3389/fphar.2021.708299. eCollection 2021.
7
Clinical pharmacogenetics and potential application in personalized medicine.临床药物遗传学及其在个性化医疗中的潜在应用。
Curr Drug Metab. 2008 Oct;9(8):738-84. doi: 10.2174/138920008786049302.
8
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.药物代谢酶和转运体的药物基因组学：对癌症治疗的影响。
Pharmgenomics Pers Med. 2011;4:11-33. doi: 10.2147/PGPM.S18861. Epub 2011 Apr 1.
9
Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450.预测肿瘤治疗反应的药物基因组学：聚焦于ATP结合盒转运蛋白和细胞色素P450
J Pers Med. 2020 Aug 28;10(3):108. doi: 10.3390/jpm10030108.
10
Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.应用基于生理学的药代动力学模型预测药物-药物相互作用的潜力。
Arch Pharm Res. 2017 Dec;40(12):1356-1379. doi: 10.1007/s12272-017-0976-0. Epub 2017 Oct 27.
引用本文的文献
1
Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study.采用简化的日内瓦鸡尾酒法在一组自由生活个体中测量CYP1A2和CYP3A4活性：一项试点研究。
Front Pharmacol. 2024 Feb 2;15:1232595. doi: 10.3389/fphar.2024.1232595. eCollection 2024.
本文引用的文献
1
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters.液体活检可实现肝脏酶和转运蛋白丰度及个体间变异性的定量分析。
Clin Pharmacol Ther. 2021 Jan;109(1):222-232. doi: 10.1002/cpt.2102. Epub 2020 Nov 25.
2
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy.模型指导下的精准剂量调整：个体化药物治疗的背景、要求、验证、实施和未来方向。
Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:225-245. doi: 10.1146/annurev-pharmtox-033020-113257. Epub 2020 Oct 9.
3
What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing.实现模型指导下的精准剂量给药常规化需要什么？第 1 届亚洲精准给药研讨会上的报告。
AAPS J. 2019 Jan 9;21(2):17. doi: 10.1208/s12248-018-0286-6.
4
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.涉及细胞色素 P450 的复杂药物-药物-基因-疾病相互作用：已发表病例报告的系统评价和临床观点。
Clin Pharmacokinet. 2018 Oct;57(10):1267-1293. doi: 10.1007/s40262-018-0650-9.
5
Applications of CYP450 testing in the clinical setting.CYP450 检测在临床环境中的应用。
Mol Diagn Ther. 2013 Jun;17(3):165-84. doi: 10.1007/s40291-013-0028-5.
6
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.CYP3A4活性变异性的遗传成分评估：一种重复给药方法。
Pharmacogenetics. 2000 Jul;10(5):373-88. doi: 10.1097/00008571-200007000-00001.
Zotero 插件